Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inga ĻAŠENKOfiledCriticalInga ĻAŠENKO
Priority to LVP-10-16ApriorityCriticalpatent/LV14132B/en
Publication of LV14132ApublicationCriticalpatent/LV14132A/en
Publication of LV14132BpublicationCriticalpatent/LV14132B/en
An invention relates to suspension usable for production of hygienic textiles, pharmaceutical and cosmetic compositions containing technologically processed amber (particles of 5 - 125 micrometers size) in combination with energizing and biologically active substances which do not cause undesirable side effects. The technologically processed amber may be in a form of powder of succinic acid or succinic acid salts.
A pharmaceutical composition comprising stable, amorphous hybrid nanopraticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component.
A pharmaceutical composition comprising stable, amorphous hybrid nanopraticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component.